Anterogen has developed stem cell therapy products since foundation of research institute in Boston in 2000. Through the experience of developing stem cell therapy products for more than 10 years, Anterogen has accumulated excellent technology and know-how and received approval of cell therapy products in each step of stem cell therapy. Therefore, Anterogen can provide various stem cell services.

- Queencell® : Autologous minimally-manipulated cell product using adipose tissues - Cupistem® injection : Cultured Autologous adipose-derived mesenchymal stem cells - Adipocell® : Immature adipocyte differentiated from adipose-derived stem cells

Anterogen received approval of the most cell therapy products in Korea, completing successfully clinical trials for damaged soft tissue, Crohn's fistula, complex fistula. Besides, various clinical studies for IgA nephropathy, diabetic foot ulcer, tendon injury, spinal injury, autoimmune disease, degenerative diseases etc. are in progress. Therefore, stored stem cells can be used appropriately for treatment of various diseases, if necessary.

Anterogen received GMP (Good Manufacturing Practice) approval by KFDA in 2007. It is controlled strictly. All the process including isolation, culture, storage of stem cells requested by you are carried out under strict control in the GMP facility to use safely.

Isolation, culture, storage of stem cells in Anterogen are under quality control test at the level of medicine. Only the suitable products after all the tests are shipped to use. therefore, stem cells with excellent quality can be provided.